STAAR Surgical to Participate in Upcoming Investor Conferences
STAAR Surgical Company announced its participation in the Stifel 2026 Virtual Ophthalmology Forum, highlighting its position as a leader in the phakic IOL market with its EVO family of Implantable Collamer® Lenses (EVO ICL™). The conference will take place on May 26, 2026, and will include an investor meeting by invitation only.
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that management will participate in the following upcoming conferences: Stifel 2026 Virtual Ophthalmology Forum Date: Tuesday, May 26, 2026 Format: Meetings and Webcast Fireside Chat Details: Investor meeting participation is by invitation only from the sponsoring brokerage firm. Webcas
